Intellectual Property Law

In Defense of Secondary Pharmaceutical Patents: A Response to the UN’s Guidelines for Pharmaceutical Patent Examination

[T]he Guidelines’ assumption that many types of pharmaceutical inventions are inherently obvious and undeserving of patent protection is incorrect and based on an oversimplified view of how these inventions come about. This Article provides an evidence-based response to the Guidelines that refutes, or at least qualifies, some of the significant conclusions and recommendations set forth by its author.


Myths and Realities of GMO Labeling Initiatives

by Drake T. Land J.D. Candidate, 2015, Indiana University Robert H. McKinney School of Law Indiana International & Comparative Law Review: Executive Articles Development Editor B.S., 2007, Ball State University; Muncie, Indiana Twitter (@draketland) LinkedIn Editor’s note: Mr. Land’s article was selected from submissions in the Indiana Law Review‘s first writing competition. Following the introduction […]


Attorneys’ Fee Awards in Patent Litigation – Emerging Trends

Andrew M. McCoy Faegre Baker Daniels LLP 300 North Meridian Street, Suite 2700 Indianapolis, IN 46204 Attorney Profile Section 285 of the Patent Act allows a prevailing party to recover attorneys’ fees in “exceptional” cases. [1]. In Octane Fitness, LLC v. Icon Health & Fitness, Inc., [2] and Highmark Inc. v. Allcare Health Management Systems, Inc., [3] the […]